Dan PK Bodnar - Jan 2, 2025 Form 4 Insider Report for Skyward Specialty Insurance Group, Inc. (SKWD)

Signature
/s/ Stacy E. Skelton, Attorney-in-Fact
Stock symbol
SKWD
Transactions as of
Jan 2, 2025
Transactions value $
-$173,238
Form type
4
Date filed
1/6/2025, 07:15 PM
Previous filing
Feb 29, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SKWD Common Stock Sale -$38.5K -785 -4.92% $49.05 15.2K Jan 2, 2025 Direct F1, F2, F3
transaction SKWD Common Stock Sale -$135K -2.7K -17.8% $49.92 12.5K Jan 2, 2025 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 On January 1, 2022, the Reporting Person was granted a Restricted Stock Award in the amount of 2,532 shares. Each share is equivalent to one share of the Company's common stock. This award fully vested on January 1, 2025. Sales transacted to cover taxes and fees incurred by vesting event.
F2 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 8, 2024.
F3 The number of securities reported reflects the May 31, 2024 acquisition of 239 shares and the December 1, 2024 acquisition of 221 shares of the Company's common stock pursuant to the Skyward Specialty Insurance Group, Inc. 2022 Employee Stock Purchase Plan ("ESPP") for the ESPP purchase periods of December 1, 2023 through May 31, 2024, and June 1, 2024 through November 30, 2024, respectively.
F4 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 11, 2024.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.47 to $50.63, inclusive. The Reporting Person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.